Showing 1 - 20 of 22 Results

Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)

Release Date
Expiration Date
Expiration Date
Activity Code(s)
Clinical Trials
Archived
Yes

Community Level Interventions to Improve Minority Health and Reduce Health Disparities (R01 - Clinical Trial Optional)

Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional)

Release Date
Expiration Date
Expiration Date
Activity Code(s)
Clinical Trials
Archived
Yes

Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed)

Release Date
Expiration Date
Expiration Date
Clinical Trials
Organizations
Archived
Yes

Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with
Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional)

Release Date
Expiration Date
Expiration Date
Activity Code(s)
Clinical Trials
Organizations
Archived
Yes

Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional)

Release Date
Expiration Date
Expiration Date
Activity Code(s)
Clinical Trials
Organizations
Archived
Yes

Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)

Release Date
Expiration Date
Expiration Date
Activity Code(s)
Clinical Trials
Organizations
Archived
Yes

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus

Notice of Special Interest (NOSI): Administrative Supplements to Support Research on Preventive Interventions with Populations that Experience Health Disparities (Admin Supp Clinical Trial Optional)

Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations

Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities

Release Date
Expiration Date
Expiration Date
Activity Code(s)
Clinical Trials
Organizations
Archived
Yes

Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19

Release Date
Expiration Date
Expiration Date
Activity Code(s)
Clinical Trials
Archived
Yes

Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations

Release Date
Expiration Date
Expiration Date
Supporting Information:
Activity Code(s)
Clinical Trials
Archived
Yes

Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations

Release Date
Expiration Date
Expiration Date
Supporting Information:
Activity Code(s)
Clinical Trials
Archived
Yes

Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities

Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)

Release Date
Expiration Date
Expiration Date
Activity Code(s)
Clinical Trials
Organizations
Archived
Yes

Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Allowed)

Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions (U01 Clinical Trial Allowed)